Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

NCT04021069 · clinicaltrials.gov ↗

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Invasive Ductal Breast Carcinoma
Invasive Lobular Breast Carcinoma

Interventions

DIAGNOSTIC_TEST: Radiomic, pathomic, and clinical markers

Sponsor

Sunnybrook Health Sciences Centre